SCHEMBL8649665

SCHEMBL8649665

FC(F)(F)n1ccnc1-c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.46
TP53 P04637 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
TSHR P16473 1/20 0.46
KDM4E B2RXH2 6/20 0.45
LMNA P02545 3/20 0.45
CCR1 P32246 2/20 0.45
CCR5 P51681 2/20 0.45
CCR8 P51685 2/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
METAP1 P53582 1/20 0.45
BLM P54132 1/20 0.45
HIF1A Q16665 1/20 0.45
DOHH Q9BU89 1/20 0.45
P4HTM Q9NXG6 1/20 0.45
GABRA1 P14867 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA3 P34903 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylphenylsulfone SCHEMBL28756302 0.85 PTGS2 (0.53) GABRA1GABRG2GABRB3GABRA3PTGS2
SCHEMBL28009342 0.79 GABRA1 (0.46) NPC1TP53SMN1; SMN2TSHRKDM4E
SCHEMBL11623898 0.78 ESR1 (0.42) NPC1KDM4ERAB9ATDP1ALPG
SCHEMBL14465345 0.76 NPC1 (0.60) NPC1TP53SMN1; SMN2TSHRKDM4E
SCHEMBL170176 0.73 KDM4E (0.52) NPC1TP53SMN1; SMN2TSHRKDM4E
SCHEMBL6357965 0.73 TP53 (0.47) NPC1TP53SMN1; SMN2TSHRKDM4E
SCHEMBL1445699 0.72 KDM4E (0.50) NPC1TP53SMN1; SMN2TSHRKDM4E
SCHEMBL10913548 0.71
SCHEMBL1445518 0.69 SMN1; SMN2 (0.47) NPC1TP53SMN1; SMN2TSHRKDM4E
Dipyridyl SCHEMBL6885910 0.68 KDM4E (0.93) NPC1TP53SMN1; SMN2TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880504-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-12-02 EP claimed
WO-1997027181-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-07-31 WO claimed